Author/year | Study design | Country | Sample size (n) | Age (mean) | Male (%) | Prevalence of mortality (%) | Time of score calculation | Measured mortality | Participant selection |
---|---|---|---|---|---|---|---|---|---|
Goulden/2018 | Retrospective | UK | 1818 | 68 | 51 | 14.6 | ED arrival | In-hospital mortality | Suspected infection |
Ranzani/2017 | Retrospective | Spain | 6874 | 66 | 62 | 6.4 | ED arrival | In-hospital mortality | Community-acquired pneumonia |
González Del Castillo/2017 | Prospective | Spain | 1071 | 84 | 51 | 6.5 | ED arrival | 30-day mortality | Suspected or confirmed infection |
Askim/2017 | Prospective | Norway | 1535 | 62 | 53 | 4.4 | ED arrival | 30-day mortality | Suspected infection |
Moskowitz/2017 | Retrospective | USA | 24,164 | 64 | 51 | 4.9 | ED arrival | In-hospital mortality | Suspected infection |
Willams/2017 | Retrospective | Australia | 8871 | 49 | 51 | 8.7 | Worst values during ED stay | 30-day mortality | Suspected infection |
Freund/2017 | Prospective | Europe | 879 | 67 | 53 | 8.4 | Worst values during ED stay | In-hospital mortality | Suspected infection |
Henning [a]/2017 | Prospective | USA | 4618 | 57 | 52 | 4.2 | Worst values during ED stay | In-hospital mortality | Suspected infection |
Henning [b]/2017 | Prospective | USA | 2132 | 57 | 52 | 3.9 | Worst values during ED stay | In-hospital mortality | Suspected infection |